Product category:
Chemicals and biochemicals
News Release from: Sigma-Aldrich | Subject: Seegene ACP
Edited by the Laboratorytalk Editorial
Team on 24 March 2004
Licencing deal covers annealing control
primers
Technology reduces the complexity of using differential display approaches to gene discovery, providing improvements in reproducibility and the elimination of false positives
Sigma-Aldrich and Seegene announce that they have entered into a licencing arrangement for access to Seegene's proprietary annealing control primers technology The Seegene ACP technology greatly improves specificity and sensitivity in hybridisation and PCR
This article was originally published on Laboratorytalk on 1 Mar 2004 at 8.00am (UK)
Related stories
First edition glycoprotein analysis manual
Features a number of general protocols for purification and deglycosylation of glycoproteins as well as segments focused on classical glycan structures and linkages
Licencing of the annealing control primers technology allows Sigma-Aldrich to further develop its product offerings for differential gene expression.
"The Seegene ACP technology significantly reduces the complexity of using differential display approaches to gene discovery," commented Keith Joliff, manager of global strategic marketing, molecular biology at Sigma-Aldrich.
"Compared to current methodologies, it provides substantial improvements in terms of reproducibility and the elimination of false positives.
"Combining our existing PCR and RT-PCR products with Seegene's ACP technology will enable Sigma to develop a series of products that will greatly enhance research efforts in the areas of gene discovery and expression profiling.".
• Sigma-Aldrich: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
